Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stem cell factor 248 (SCF248) is the primary cleavable isoform of the cytokine Stem cell factor (SCF), also known as KIT ligand [1, 11]. It is encoded by the KITLG gene and serves as the essential ligand for the c-Kit receptor tyrosine kinase (CD117) [1, 8]. SCF248 contains a unique proteolytic cleavage site encoded by exon 6, which allows its extracellular domain to be shed as a soluble factor, whereas the shorter SCF220 isoform remains largely membrane-bound [7, 11]. This soluble form is significantly upregulated in chronic inflammatory and fibrotic conditions, such as idiopathic pulmonary fibrosis (IPF) and asthma, where it promotes the accumulation and activation of mast cells and pro-fibrotic fibroblasts [1, 2, 6]. Therapeutic strategies targeting SCF248, such as the monoclonal antibody INS1148, aim to selectively neutralize this soluble isoform to inhibit pathogenic remodeling while sparing the homeostatic functions of membrane-bound SCF, such as erythropoiesis and tissue repair [10, 12]. This selective approach provides a mechanism to modulate c-Kit signaling in disease contexts while potentially minimizing systemic toxicities associated with non-selective c-Kit inhibition [12].
Selective neutralization of the soluble SCF248 isoform to inhibit pathogenic c-Kit-mediated signaling in mast cells and fibroblasts while preserving the homeostatic functions of the membrane-bound SCF isoform.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stem cell factor 248 (SCF248).